&nbsp;

fitp-map-ED-3-try-22-11-19.html

Nov 2019

Document

BiosimilarPatients.pdf

Nov 2019

Document

BiosimilarPatients-FR.pdf

Nov 2019

Regimen

MFOLFOX6

Cancer Type:

Gastrointestinal,

Neuroendocrine (GI)

Intent: Palliative

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2024

Guidelines and Advice

Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines: January to June 2019

Status: Current
ID: pet 2019-1
Version: N/A

Nov 2019

Blog post

Reducing barriers to cancer screening for trans and non-binary people

Dr. Edward Kucharski Among the many healthcare challenges facing trans and non-binary people, cancer poses a multi-edge threat. Not only are trans...

Nov 2019

Document

ocsHeadingChapter2.jpg

Nov 2019

Document

ocsHeadingBackground2.png

Nov 2019

Regimen

CRBPETOP+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

CRBPETOP(PO)+ATEZ

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

ODB - General Benefit

etoposide - oral capsules

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

Quick Link(s):

Regimen Monograph

Nov 2023

Regimen

ATEZ(MNT)

Cancer Type:

Lung,

Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Atezolizumab - In Combination with Etoposide and Platinum for Extensive-Stage Small Cell Lung Cancer

Drugs Used:

atezolizumab

... Show more tags

Quick Link(s):

Regimen Monograph

Mar 2024

Regimen

CISPETOP(IND)

Cancer Type:

Gynecologic,

Gestational Trophoblastic Disease

Intent: Adjuvant, Curative

Drugs Used:

CISplatin,

etoposide

... Show more tags